Hypothesis for the development of persistent methamphetamine-induced psychosis

被引：0
|
作者：
Hsieh, J. [1 ]
Stein, D. J. [1 ]
Howells, F. M. [1 ]
机构：
[1] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7700 Rondebosch, South Africa
来源：
SOUTH AFRICAN JOURNAL OF PSYCHIATRY | 2013年 / 19卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [11] Persistent expression of methamphetamine-induced CTA in periadolescent rats
    Harrod, Steven B.
    Lacy, Ryan T.
    Ballina, Lauren E.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 96 (04) : 515 - 520
  • [12] Methamphetamine-induced psychosis: Clinical features, treatment modalities and outcomes
    Thomas, Eileen
    Lategan, Helena
    Verster, Chris
    Kidd, Martin
    Weich, Lize
    SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2016, 22 (01)
  • [13] Methamphetamine-induced persistent deficits in monoamine systems and their consequences.
    Hanson, GR
    Fleckenstein, AE
    Keefe, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U476 - U476
  • [14] Dopamine is not essential for the development of methamphetamine-induced neurotoxicity
    Yuan, Jie
    Darvas, Martin
    Sotak, Bethany
    Hatzidimitriou, George
    McCann, Una D.
    Palmiter, Richard D.
    Ricaurte, George A.
    JOURNAL OF NEUROCHEMISTRY, 2010, 114 (04) : 1135 - 1142
  • [15] METHAMPHETAMINE-INDUCED PSYCHOSIS AND MENTAL IMPAIRMENT: A CHALLENGE FROM NEW ZEALAND
    Freckelton, Ian
    JOURNAL OF LAW AND MEDICINE, 2019, 27 (02) : 284 - 293
  • [16] Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients
    Zarrabi, Homa
    Khalkhali, Mohammadrasoul
    Hamidi, Azam
    Ahmadi, Reza
    Zavarmousavi, Maryam
    BMC PSYCHIATRY, 2016, 16
  • [17] Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients
    Homa Zarrabi
    Mohammadrasoul Khalkhali
    Azam Hamidi
    Reza Ahmadi
    Maryam Zavarmousavi
    BMC Psychiatry, 16
  • [18] Evidence for Shared Genetic Risk Between Methamphetamine-Induced Psychosis and Schizophrenia
    Masashi Ikeda
    Yuko Okahisa
    Branko Aleksic
    Mujun Won
    Naoki Kondo
    Nobuya Naruse
    Kumi Aoyama-Uehara
    Ichiro Sora
    Masaomi Iyo
    Ryota Hashimoto
    Yoshiya Kawamura
    Nao Nishida
    Taku Miyagawa
    Masatoshi Takeda
    Tsukasa Sasaki
    Katsushi Tokunaga
    Norio Ozaki
    Hiroshi Ujike
    Nakao Iwata
    Neuropsychopharmacology, 2013, 38 : 1864 - 1870
  • [19] Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
    Okazaki, Kosuke
    Makinodan, Manabu
    Yamamuro, Kazuhiko
    Takata, Tomoyo
    Kishimoto, Toshifumi
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 3195 - 3198
  • [20] THE SYMPTOM PROFILE AND CLINICAL COURSE OF METHAMPHETAMINE-INDUCED PSYCHOSIS: A SYSTEMATIC REVIEW
    Voce, Alexandra
    McKetin, Rebecca
    Calabria, Bianca
    Burns, Richard
    Castle, David
    DRUG AND ALCOHOL REVIEW, 2016, 35 : 72 - 73
12345